Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Adverum Biotechnologies Inc ADVM

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec Ixo-vec, a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:ADVM)

Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition

PR Newswire 4 days ago

Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly

GlobeNewswire 12 days ago

Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire November 19, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMP

PR Newswire November 19, 2025

Halper Sadeh LLC Encourages CMA, ADVM, HOUS Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire November 18, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMP

GlobeNewswire November 18, 2025

HALPER SADEH LLC ENCOURAGES ADVM, PLYM, RNA SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

PR Newswire October 27, 2025

ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders

Business Wire October 27, 2025

Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM

Business Wire October 25, 2025

Opinion & Analysis (NDAQ:ADVM)

No current opinion is available.

Bullboard Posts (NDAQ:ADVM)

Using technical analysis for this stock.

It is showing strength to the upside for shareholders today anyway,so good luck to all
coolfooldumbguy - September 23, 2025

advm is on fire, 2 solid news pieces

https://seekingalpha.com/article/4156557-adverum-lot-done-lot
RetirementFund - March 15, 2018

ADVM is poised for a huge week!

very interested in todays ceo keynote in Boston, should be a great week for advm investors.
RetirementFund - March 12, 2018

Why is knoone talking about advm is about to explode!

ceo preaentation Monday have to believe its big news!
RetirementFund - March 2, 2018

What is up with ADVM?

I have a position in the company and can't find much on it news wise?  anyone want to start talking about this one?  
RetirementFund - February 23, 2018

$200 Million in cash

It equals to $4.26 per share
yohanlee - April 6, 2017